Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ritalin-SR 20mg tablets
0404000M0BBABAH
|
Ritalin | Methylphenidate hydrochloride | Central Nervous System | 1 |
|
Atenza XL 18mg tablets
0404000M0BQADAM
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 27mg tablets
0404000M0BQACAT
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 36mg tablets
0404000M0BQABAN
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 54mg tablets
0404000M0BQAAAR
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Concerta 27mg modified-release tablets
0404000M0BDADAT
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Concerta 54mg modified-release tablets
0404000M0BDACAR
|
Concerta | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 10mg tablets
0404000M0BCABAA
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 20mg tablets
0404000M0BCACAK
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Equasym 5mg tablets
0404000M0BCAAAJ
|
Equasym | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 10mg capsules
0404000M0BPAAAU
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 20mg capsules
0404000M0BPABAQ
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 30mg capsules
0404000M0BPACAV
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Focusim XL 40mg capsules
0404000M0BPADAW
|
Focusim | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Kixel XL 18mg tablets
0404000M0BSAAAM
|
Kixel | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Kixel XL 27mg tablets
0404000M0BSABAT
|
Kixel | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Kixel XL 36mg tablets
0404000M0BSACAN
|
Kixel | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Kixel XL 54mg tablets
0404000M0BSADAR
|
Kixel | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 12.5mg/5ml oral solution
0404000M0AAAIAI
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 2.5mg/5ml oral solution
0404000M0AAALAL
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 20mg MR chew tab sugar free
0404000M0AABDBD
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 20mg/5ml oral solution
0404000M0AAAGAG
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 30mg MR chew tab sugar free
0404000M0AABEBE
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 40mg MR chew tab sugar free
0404000M0AABFBF
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Methylphenidate 6.25mg/5ml oral solution
0404000M0AAADAD
|
Methylphenidate hydrochloride | Methylphenidate hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.